comparemela.com

Latest Breaking News On - Hudson bay capital management - Page 1 : comparemela.com

TIG Advisors LLC Has $93 63 Million Position in Capri Holdings Limited (NYSE:CPRI)

TIG Advisors LLC raised its stake in shares of Capri Holdings Limited (NYSE:CPRI – Free Report) by 9.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,863,562 shares of the company’s stock after acquiring an additional 158,303 shares during the quarter. Capri comprises 11.7% of TIG Advisors LLC’s portfolio, making the stock […]

Seven Eight Capital LP Purchases 26,831 Shares of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Seven Eight Capital LP increased its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,906 shares of the biopharmaceutical company’s stock after purchasing an additional 26,831 shares during the […]

Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Decline in Short Interest

Vicarious Surgical Inc (NYSE:RBOT – Get Free Report) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 5,210,000 shares, a drop of 21.2% from the April 30th total of 6,610,000 shares. Based on an average daily trading volume, of 596,300 shares, the short-interest ratio is presently […]

National Bankshares Raises Algonquin Power & Utilities (NYSE:AQN) Price Target to $7 25

Algonquin Power & Utilities (NYSE:AQN – Free Report) had its target price boosted by National Bankshares from $6.75 to $7.25 in a research report released on Tuesday morning, BayStreet.CA reports. National Bankshares currently has a sector perform rating on the utilities provider’s stock. Other analysts have also issued reports about the company. Wells Fargo & […]

Disc Medicine, Inc (NASDAQ:IRON) Receives Average Recommendation of Moderate Buy from Analysts

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.